Anju Sunil Kaudanya
About Anju Sunil Kaudanya
Data last updated:
Anju Sunil Kaudanya is a Director at Novo Medi Sciences Private Limited (since 2013), Director at Saika Maritime Private Limited (since 2009) and Director at Novo Biologicals Private Limited (since 2023), and holds 3 more current directorships. The companies operate in Pharma, Transport and Logistics and Paper. The 3 current companies with reported revenue have a combined latest revenue of ₹97.57 Cr; the largest is Novo Medi Sciences Private Limited at ₹96.23 Cr (FY 2023). Earlier, Anju Sunil Kaudanya was a Director at Vhb Pharmaceuticals Private Limited (2001–2012) and Director at Vhb Medi Sciences Limited (2007–2012) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novo Medi Sciences Private Limited U33110MH2013PTC245027 | Director | 29 Jun 2013 | 2013 | ₹96.23 Cr (FY 2023) | Active |
 Saika Maritime Private Limited U63032MH2009PTC189595 | Director | 15 Jan 2009 | 2009 | ₹1.33 Cr (FY 2025) | Active |
| Novo Biologicals Private Limited U46497MH2023PTC412674 | Director | 23 Oct 2023 | 2023 | ₹1,305 (FY 2025) | Active |
| Remedy Biologicals Private Limited U21001MH2025PTC448402 | Director | 15 May 2025 | 2025 | Active | |
| Novo Biosciences Llp ACC-3932 | Partner | 07 Aug 2023 | 2023 | Active | |
 Agk Healthcare Private Limited U74999MH2016PTC282997 | Director | 28 Jun 2016 | 2016 | Dormant Under Section 455 |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vhb Pharmaceuticals Private Limited U24231MH1995PTC094365 | Director | 30 Mar 2001 | 1995 | Active | |
| Vhb Medi Sciences Limited U24232MH2007PLC174054 | Director | 12 Sep 2007 | 2007 | ₹159 Cr (FY 2025) | Active |
| Safe Green Revenue Solutions Private Limited U67100MH2015PTC266264 | Director | 03 Jul 2015 | 2015 | ₹1.7 Lakh (FY 2025) | Active |
| Vhb Life Sciences Limited U74900MH2007PLC171648 | Director | 13 Jun 2007 | 2007 | ₹13.99 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Anju Sunil Kaudanya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Forum Vipulkumar Bhagat | 07288677 | Novo Medi Sciences Private Limited , Novo Biologicals Private Limited | Director |
| Karan Vipul Bhagat | 07288687 | Novo Medi Sciences Private Limited , Novo Biologicals Private Limited and 1 more | Director |
| Vipulkumar Rameshchandra Bhagat | 01756677 | Novo Medi Sciences Private Limited , Novo Biologicals Private Limited and 1 more | Director |
| Surekha Sunil Gupta | 07554974 | Saika Maritime Private Limited , Agk Healthcare Private Limited | Director |
| Sunil Santosh Gupta | 11108730 | Remedy Biologicals Private Limited | Director |
| Vikram Dey | 09286253 | Remedy Biologicals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anju Sunil Kaudanya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anju Sunil Kaudanya
Anju Sunil Kaudanya currently holds 6 directorships: Novo Medi Sciences Private Limited (Director, since 29 Jun 2013, revenue ₹96.23 Cr (FY 2023)); Saika Maritime Private Limited (Director, since 15 Jan 2009, revenue ₹1.33 Cr (FY 2025)); Novo Biologicals Private Limited (Director, since 23 Oct 2023, revenue ₹1,305 (FY 2025)); Remedy Biologicals Private Limited (Director, since 15 May 2025); Novo Biosciences Llp (Partner, since 07 Aug 2023); and 1 more.
Anju Sunil Kaudanya was first appointed on 30 Mar 2001 as Director at Vhb Pharmaceuticals Private Limited. The most recent appointment on record is 15 May 2025 at Remedy Biologicals Private Limited.
The 3 current companies of Anju Sunil Kaudanya that report revenue have a combined latest revenue of ₹97.57 Cr: Novo Medi Sciences Private Limited ₹96.23 Cr (FY 2023); Saika Maritime Private Limited ₹1.33 Cr (FY 2025); Novo Biologicals Private Limited ₹1,305 (FY 2025).
Anju Sunil Kaudanya held 4 earlier board appointments: Vhb Pharmaceuticals Private Limited (Director, 30 Mar 2001 to 18 Dec 2012); Vhb Medi Sciences Limited (Director, 12 Sep 2007 to 18 Dec 2012); Safe Green Revenue Solutions Private Limited (Director, 03 Jul 2015 to 01 Aug 2016); Vhb Life Sciences Limited (Director, 13 Jun 2007 to 18 Dec 2012).
The current boards of Anju Sunil Kaudanya's companies include Forum Vipulkumar Bhagat (Novo Medi Sciences Private Limited), Karan Vipul Bhagat (Novo Medi Sciences Private Limited), Vipulkumar Rameshchandra Bhagat (Novo Medi Sciences Private Limited), Surekha Sunil Gupta (Saika Maritime Private Limited), Sunil Santosh Gupta (Remedy Biologicals Private Limited), Vikram Dey (Remedy Biologicals Private Limited).